Absence of anti‐envelope antibodies and clearance of hepatitis C virus in a cohort of Irish women infected in 1977

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Viral Hepatitis

• Publication date

  1996-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2893.1997.00074.xPMID 9430357
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis.

  2008cited by this paper
• Detection of antibodies to a putative hepatitis G virus envelope protein.

  1997cited by this paper
• Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection

  1996cited by this paper
• Detection of Antibody to Hepatitis C Virus E2 Recombinant Antigen among Samples Indeterminate for Anti‐HCV after Wide Serological Testing and Correlation with Viremia

  1996cited by this paper
• Infection with hepatitis G virus among recipients of plasma products.

  1996cited by this paper
• Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin.

  1995cited by this paper
• Antibody to hepatitis C virus second envelope (HCV‐E2) glycoprotein: A new marker of HCV infection closely associated with viremia

  1995cited by this paper
• Evaluation of indeterminate c22‐3 reactivity in volunteer blood donors

  1994cited by this paper
• High detection rate of hepatitis C virus E2 antibody in patients with type C hepatitis

  1993cited by this paper

• Immunopathogenesis of Liver Injury During Hepatitis C Virus Infection

  2019cites this paper
• Immunoassay of anti-HCV and seroepidemiological surveillance of hepatitis C virus infection

  2015cites this paper
• 25. Hepatitis C

  2011cites this paper
• Immunological determinants of the outcomes from primary hepatitis C infection

  2009cites this paper
• Protective immunity against hepatitis C virus infection

  2006cites this paper
• Timing of lamivudine administration according to Child class in patients with decompensated cirrhosis

  2005cites this paper
• Immunopathogenesis of hepatitis C virus infection

  2004cites this paper
• Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort.

  2004cites this paper
• Immunopathogenesis of hepatitis C virus infection

  2001cites this paper
• A study of hepatitis C prevalence in healthcare workers in the West of Scotland

  2001cites this paper
• Acute hepatitis C

  2001cites this paper
• Vaccine Development for Hepatitis C

  2000cites this paper
• A cohort study of hepatitis C virus (HCV) infection in an HCV epidemic area of Japan: age and sex-related seroprevalence of anti-HCV antibody, frequency of viremia, biochemical abnormality and histological changes.

  1999cites this paper
• Significance of the anti-E2 response in self-limited and chronic hepatitis C virus infections in chimpanzees and in humans.

  1999cites this paper
• Molecular and therapeutic advances in the management of chronic hepatitis B and C

  1998cites this paper